210 related articles for article (PubMed ID: 26139072)
21. Liquid chromatography-tandem mass spectrometric assay for the mutated BRAF inhibitor dabrafenib in mouse plasma.
Sparidans RW; Durmus S; Schinkel AH; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Apr; 925():124-8. PubMed ID: 23537694
[TBL] [Abstract][Full Text] [Related]
22. Bioanalytical LC-MS/MS method development and validation of novel antidiabetic candidate S007-1261 in rat plasma and its application to pharmacokinetic and oral bioavailability studies.
Misra A; Kushwaha HN; Gautam N; Singh B; Verma PC; Pratap R; Singh SK
Drug Res (Stuttg); 2014 Aug; 64(8):399-405. PubMed ID: 24258707
[TBL] [Abstract][Full Text] [Related]
23. Rapid and sensitive method for quantification of gestodene in human plasma as the oxime derivative by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and its application to bioequivalence study.
Saxena A; Gupta A; Kasibhatta R; Bob M; Kumar VP; Purwar B
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jan; 945-946():240-6. PubMed ID: 24361980
[TBL] [Abstract][Full Text] [Related]
24. Highly sensitive method for the determination of JI-101, a multi-kinase inhibitor in human plasma and urine by LC-MS/MS-ESI: method validation and application to a clinical pharmacokinetic study.
Sharma S; Dubey NK; Dasgupta AK; Sahu M; Benjamin B; Mullangi R; Srinivas NR
Biomed Chromatogr; 2012 Feb; 26(2):232-8. PubMed ID: 21594880
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of a liquid chromatography-tandem mass spectrometry for the determination of BPR0L075, a novel antimicrotuble agent, in rat plasma: application to a pharmacokinetic study.
Chang YW; Chen WC; Lin KT; Chang L; Yao HT; Hsieh HP; Lan SJ; Chen CT; Chao YS; Yeh TK
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):162-8. PubMed ID: 17005456
[TBL] [Abstract][Full Text] [Related]
26. Fast LC-MS/MS analysis of free oxysterols derived from reactive oxygen species in human plasma and carotid plaque.
Helmschrodt C; Becker S; Schröter J; Hecht M; Aust G; Thiery J; Ceglarek U
Clin Chim Acta; 2013 Oct; 425():3-8. PubMed ID: 23827692
[TBL] [Abstract][Full Text] [Related]
27. Reliable LC-MS/MS assay for the estimation of rilpivirine in human plasma: application to a bioequivalence study and incurred sample reanalysis.
Gupta A; Guttikar S; Patel Y; Shrivastav PS; Sanyal M
Drug Test Anal; 2015 Apr; 7(4):290-9. PubMed ID: 24817216
[TBL] [Abstract][Full Text] [Related]
28. Liquid chromatography-tandem mass spectrometric assay for the PARP inhibitor rucaparib in plasma.
Sparidans RW; Durmus S; Schinkel AH; Schellens JH; Beijnen JH
J Pharm Biomed Anal; 2014 Jan; 88():626-9. PubMed ID: 24216281
[TBL] [Abstract][Full Text] [Related]
29. Validated LC-MS-MS method for the determination of quetiapine in human plasma: application to a pharmacokinetic study.
Pan RN; Kuo BP; Pao LH
J Chromatogr Sci; 2012 Mar; 50(3):277-82. PubMed ID: 22337805
[TBL] [Abstract][Full Text] [Related]
30. Sensitive method for the determination of ibutilide in human plasma by liquid chromatography-tandem mass spectrometry.
Tian L; Li Y; Huang Y; Kuang F; Li F; Hua L
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):81-5. PubMed ID: 15664337
[TBL] [Abstract][Full Text] [Related]
31. A highly sensitive and selective method for the determination of leukotriene B4 (LTB4) in ex vivo stimulated human plasma by ultra fast liquid chromatography-tandem mass spectrometry.
Lin W; Huang MQ; Xue X; Bertelsen K; Chen G; Zhao H; Lin ZJ; Fourie A; de Jong J; Weng N
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Apr; 925():54-62. PubMed ID: 23523878
[TBL] [Abstract][Full Text] [Related]
32. Fast simultaneous quantitative analysis of FTY720 and its metabolite FTY720-P in human blood by on-line solid phase extraction coupled with liquid chromatography-tandem mass spectrometry.
Emotte C; Deglave F; Heudi O; Picard F; Kretz O
J Pharm Biomed Anal; 2012 Jan; 58():102-12. PubMed ID: 22018890
[TBL] [Abstract][Full Text] [Related]
33. Determination of ranolazine in human plasma by LC-MS/MS and its application in bioequivalence study.
Bhaumik U; Ghosh A; Sarkar AK; Bose A; Selvan PS; Sengupta P; Chakraborty US; Ghosh D; Pal TK
J Pharm Biomed Anal; 2008 Dec; 48(5):1404-10. PubMed ID: 18986788
[TBL] [Abstract][Full Text] [Related]
34. Analysis of 21-hydroxy deflazacort in human plasma by UPLC-MS/MS: application to a bioequivalence study in healthy volunteers.
Patel DP; Sharma P; Patel BM; Sanyal M; Singhal P; Shrivastav PS
J Pharm Biomed Anal; 2013 Nov; 85():213-7. PubMed ID: 23973630
[TBL] [Abstract][Full Text] [Related]
35. Simultaneous determination of a novel KDR kinase inhibitor and its N-oxide metabolite in human plasma using 96-well solid-phase extraction and liquid chromatography/tandem mass spectrometry.
Xu Y; Du L; Soli ED; Braun MP; Dean DC; Musson DG
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Mar; 817(2):287-96. PubMed ID: 15686997
[TBL] [Abstract][Full Text] [Related]
36. Validation and determination of taselisib, a β-sparing phosphoinositide 3-kinase (PI3K) inhibitor, in human plasma by LC-MS/MS.
Ding X; Faber K; Shi Y; McKnight J; Dorshorst D; Ware JA; Dean B
J Pharm Biomed Anal; 2016 Jul; 126():117-23. PubMed ID: 27187764
[TBL] [Abstract][Full Text] [Related]
37. Systematic evaluation of matrix effect and cross-talk-free method for simultaneous determination of zolmitriptan and N-desmethyl zolmitriptan in human plasma: a sensitive LC-MS/MS method validation and its application to a clinical pharmacokinetic study.
Patel B; Suhagia BN; Jangid AG; Mistri HN; Desai N
Biomed Chromatogr; 2016 Mar; 30(3):447-58. PubMed ID: 26189757
[TBL] [Abstract][Full Text] [Related]
38. Multiplexed LC-MS/MS method for the simultaneous quantitation of three novel hepatitis C antivirals, daclatasvir, asunaprevir, and beclabuvir in human plasma.
Jiang H; Kandoussi H; Zeng J; Wang J; Demers R; Eley T; He B; Burrell R; Easter J; Kadiyala P; Pursley J; Cojocaru L; Baker C; Ryan J; Aubry AF; Arnold ME
J Pharm Biomed Anal; 2015 Mar; 107():409-18. PubMed ID: 25676854
[TBL] [Abstract][Full Text] [Related]
39. Development and validation of an ultrasensitive LC-MS/MS method for the quantification of cetagliptin in human plasma and its application in a microdose clinical trial.
Bai H; Lu J; Cheng X; Liu L; Zhang W; Wei Y; Wang Y; Liu J; Ding J; Yu Q; Zhang Y; Chen G; Fan Y; Wang X
Biomed Chromatogr; 2021 Mar; 35(3):e4994. PubMed ID: 32986878
[TBL] [Abstract][Full Text] [Related]
40. Microdose clinical trial: quantitative determination of fexofenadine in human plasma using liquid chromatography/electrospray ionization tandem mass spectrometry.
Yamane N; Tozuka Z; Sugiyama Y; Tanimoto T; Yamazaki A; Kumagai Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):118-28. PubMed ID: 17804306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
